MktsMarkets

Neuropace, Inc.
NASDAQ: NPCEKey statistics
NPCE News
Stories mentioning NPCE from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 22,068 | 26,588 | 27,354 | 23,520 | 22,524 | 21,466 | 21,060 | 19,256 |
| Cost of Goods Sold | 4,020 | 6,010 | 6,186 | 5,388 | 5,182 | 5,278 | 5,640 | 5,122 |
| Gross Profit | 18,048 | 20,578 | 21,168 | 18,132 | 17,342 | 16,188 | 15,420 | 14,134 |
| Operating Expenses | ||||||||
| Research & Development | 7,189 | 7,027 | 6,576 | 6,845 | 7,440 | 6,050 | 5,754 | 6,065 |
| Sales General & Admin | 15,049 | 13,791 | 13,909 | 14,299 | ||||
| Total Operating Expenses | 23,616 | 22,345 | 23,768 | 24,956 | 22,489 | 19,841 | 19,663 | 20,364 |
| Operating Income (Loss) | (5,568) | (1,767) | (2,600) | (6,824) | (5,147) | (3,653) | (4,243) | (6,230) |
| Interest Income | 565.00 | 638.00 | 667.00 | 718.00 | 793.00 | 681.00 | 754.00 | 762.00 |
| Interest Expense | ||||||||
| Other Expense | (165.00) | 0.00 | 82.00 | (486.00) | (82.00) | (86.00) | 219.00 | 120.00 |
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income (Loss) | (6,689) | (2,729) | (3,496) | (8,651) | (6,589) | (5,250) | (5,452) | (7,514) |
| Earnings Per Share (Basic) | (0.20) | (0.08) | (0.11) | (0.26) | (0.21) | (0.18) | (0.19) | (0.26) |
| Earnings Per Share (Diluted) | (0.20) | (0.08) | (0.11) | (0.26) | (0.21) | (0.18) | (0.19) | (0.26) |
| Weighted Average Shares Outstanding (Basic) | 33,717 | 32,722 | 33,135 | 32,863 | 31,481 | 29,126 | 29,445 | 28,853 |
| Weighted Average Shares Outstanding (Diluted) | 33,717 | 32,722 | 33,135 | 32,863 | 31,481 | 29,126 | 29,445 | 28,853 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About NPCE
Neuropace, Inc. (NASDAQ: NPCE) is a stock listed on the Nasdaq Stock Market under the ticker symbol NPCE. It last traded at $13.26 (Nov 9, 2026, 2:34 PM ET), up 6.1% on the day. That gives Neuropace a market capitalisation of $429.1M.
Over the past 52 weeks NPCE has traded between $12.00 and $19.60.
Revenue for the quarter ended Mar 31, 2026 was $22.1M; a net loss of $6.7M. Revenue was down 2.0% from $22.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $22.1M | -$6.7M | -30.3% |
| Dec 31, 2025 | $26.6M | -$2.7M | -10.3% |
| Sep 30, 2025 | $27.4M | -$3.5M | -12.8% |
| Jun 30, 2025 | $23.5M | -$8.7M | -36.8% |
From Neuropace’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…